Calidi Biotherapeutics Inc’s recent filing unveils that its CEO and Chairman of the Board Camaisa Allan unloaded Company’s shares for reported $16200.0 on Dec 17 ’24. In the deal valued at $1.62 per share,10,000 shares were sold. As a result of this transaction, Camaisa Allan now holds 66,712 shares worth roughly $44029.920000000006.
H.C. Wainwright initiated its Calidi Biotherapeutics Inc [CLDI] rating to a Buy in a research note published on November 22, 2023; the price target was $11. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in early October with a ‘”an Outperform”‘ rating.
Price Performance Review of CLDI
On Tuesday, Calidi Biotherapeutics Inc [AMEX:CLDI] saw its stock fall -0.42% to $0.66. Over the last five days, the stock has lost -21.24%. Calidi Biotherapeutics Inc shares have fallen nearly -42.84% since the year began. Nevertheless, the stocks have fallen -93.27% over the past one year. While a 52-week high of $16.80 was reached on 01/07/25, a 52-week low of $0.65 was recorded on 01/28/25. SMA at 50 days reached $1.5803, while 200 days put it at $1.6868.
Levels Of Support And Resistance For CLDI Stock
The 24-hour chart illustrates a support level at 0.6211, which if violated will result in even more drops to 0.5849. On the upside, there is a resistance level at 0.6918. A further resistance level may holdings at 0.7263. The Relative Strength Index (RSI) on the 14-day chart is 26.40, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.2182, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.65%. Stochastics %K at 4.30% indicates the stock is a buying.
How much short interest is there in Calidi Biotherapeutics Inc?
A steep rise in short interest was recorded in Calidi Biotherapeutics Inc stocks on 2024-10-31, growing by 0.42 million shares to a total of 0.59 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 0.16 million shares. There was a rise of 72.5%, which implies that there is a positive sentiment for the stock.
